← Eichor
Study identifier: NCT06597331 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital

Condition: Chronic Obstructive Pulmonary Disease · Takotsubo Cardiomyopathy · Acute Heart Failure  ·  Sponsor: Sahlgrenska University Hospital

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective observational study is to investigate to what extent acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) triggers Takotsubo-stunning, and how this affects the outcome for these patients. The main questions it aims to answer are: 1. What is cumulative incidence of Takotsubo-stunning in patients hospitalized for AE-COPD at Sahlgrenska University Hospital/S (Gothenburg, Sweden)? 2. Among patients hospitalized for AE-COPD at Sahlgrenska University Hospital/S, what is the risk of in-hospital clinical manifestations of acute heart failure in patients with Takotsubo-stunning compared to those without?

This description comes directly from the study's public registry record.

Talk to the study team

Rickard Zeijlon, M.D. PhD  ·  +46705821889  ·  rickard.zeijlon@vgregion.se

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Emergency Medicine and Geriatrics, Sahlgrenska University Hospital/SGothenburg, Region Västra Götaland, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06597331